Biotech-Focused Fund Adds Million: Immunome Bet Surges
A leading biotech-focused fund just boosted its Immunome position by a material amount as the stock surged. This arti...
This piece outlines scenarios where a lifecycle fund may be preferable to a target date fund, helping you tailor your retirement strategy.
23,155 articlesA leading biotech-focused fund just boosted its Immunome position by a material amount as the stock surged. This arti...
A major move by hedge fund incline global to liquidate its Maplebear stake prompts a closer look at CART stock. Read ...
A trusted economics forecaster nailed a 4.2% inflation reading months ahead of the Federal Reserve. Now, they offer a...
ATRenew (RERE) 2026 earnings in Q1 offer a clearer view of the company’s path forward. This guide breaks down what to...
Global headlines rarely stay abroad when markets react. This article explains how geopolitical shocks can affect pers...
A boutique investor firm makes a bold healthcare bet by accumulating over 2 million Baxter International shares. The ...
Investors are reassessing opportunities in firearm makers as policy shifts and demand cycles test the staying power o...
Decades of secrecy around cutting-edge defense programs are giving way to public scrutiny and market reassessment. In...
Tech markets climbed on Feb 19, 2026 as cloud names led the gains. Analysts point to AI demand, enterprise migrations...
U.S. equities climbed on Friday as top performing stocks led a broad rally, with technology and energy names pushing ...
A new privacy law takes effect March 5, ending broad trigger-lead marketing for loans. Lenders must pivot to consent-...
RF Industries (RFIL) faces a mix of aerospace, medical, and data-communications demand in 2026. This guide breaks dow...